Skip to content

Homoeopathic medicines for the treatment of Insomnia.

Assessing The Efficacy of Individualised Homoeopathic Medicines Selected Through Synthetic Repertory in Treatment of Insomnia: A Single-Blind Randomized Placebo-Controlled Clinical Trial. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057225
Enrollment
100
Registered
2023-09-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G470- Insomnia

Interventions

Intervention1: HOMOEOPATHIC MEDICINES: Administration of indicated homeopathic medicines in centesimal potencies as per the need of the patient and as decided appropriate by the investigator. Each dos

Sponsors

Laxmiben Homoeopathy Institute and Research Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects who have been diagnosed as per the DSM-V Diagnostic Criteria for Insomnia. 2. Subjects will be selected irrespective of their sex, socio-economic status, and occupation. 3. Age between 18 to 50 years. 4. If the subject is illiterate then the relatives or family members will be assessed to fill the sleep diary. 5. Subjects who are willing to participate and sign the written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Subjects suffering from the complications of insomnia. 2. Subjects are undergoing treatment with non-steroidal anti-inflammatory drugs (NSAIDs), antiemetics, triptans, ergot alkaloids, and estrogen for 2 weeks prior to enrollment in the study. 3. Subjects suffering from uncontrolled systemic illness or psychiatric diseases and/or life-threatening infections. 4. Substance abuse and/or dependence. 5. Pregnant or lactating women. 6. Subjects already undergoing homoeopathic treatment elsewhere for any chronic disease within the last 02 months. 7. Non-compliance to the study treatment/ protocol.

Design outcomes

Primary

MeasureTime frame
Consensus Sleep Diary CoreTimepoint: At baseline, every month, up to 6 months

Secondary

MeasureTime frame
Insomnia Severity Index (ISI)Timepoint: At basline, 03 Months, 06 Months;WHOQOL-BREFTimepoint: At basline, 03 Months, 06 Months

Countries

India

Contacts

Public ContactDr Avinash Patel

Parul University

jignesh.patel79013@paruluniversity.ac.in9909949221

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026